NOVA WELLNESS GROUP BERHAD
KLSE (MYR): NOVA (0201)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.95
Today's Change
+0.015 (1.60%)
Day's Change
0.93 - 0.95
Trading Volume
101,800
Financial
Market Cap
302 Million
NOSH
318 Million
Latest Quarter
31-Mar-2022 [#3]
Announcement Date
24-May-2022
Next Quarter
30-Jun-2022
Est. Ann. Date
09-Sep-2022
Est. Ann. Due Date
29-Aug-2022
QoQ | YoY
10.61% | 41.08%
Revenue | NP to SH
49,777.000 | 18,879.000
RPS | P/RPS
15.66 Cent | 6.07
EPS | P/E | EY
5.94 Cent | 16.00 | 6.25%
DPS | DY | Payout %
2.00 Cent | 2.11% | 33.66%
NAPS | P/NAPS
0.31 | 3.07
QoQ | YoY
8.14% | 24.92%
NP Margin | ROE
37.93% | 19.17%
F.Y. | Ann. Date
31-Mar-2022 | 24-May-2022
Latest Audited Result
30-Jun-2021
Announcement Date
18-Oct-2021
Next Audited Result
30-Jun-2022
Est. Ann. Date
18-Oct-2022
Est. Ann. Due Date
27-Dec-2022
Revenue | NP to SH
40,482.000 | 14,557.000
RPS | P/RPS
12.73 Cent | 7.46
EPS | P/E | EY
4.58 Cent | 20.75 | 4.82%
DPS | DY | Payout %
1.80 Cent | 1.89% | 39.29%
NAPS | P/NAPS
0.30 | 3.17
YoY
11.93%
NP Margin | ROE
35.96% | 15.27%
F.Y. | Ann. Date
30-Jun-2021 | 09-Sep-2021
Revenue | NP to SH
51,402.666 | 19,317.333
RPS | P/RPS
16.17 Cent | 5.88
EPS | P/E | EY
6.08 Cent | 15.63 | 6.40%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
0.44% | 42.25%
NP Margin | ROE
37.58% | 19.61%
F.Y. | Ann. Date
31-Mar-2022 | 24-May-2022
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
Be the first to like this. Showing 50 of 827 comments
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
https://www.reuters.com/article/health-coronavirus-emirates/update-1-u...
2020-12-09 15:26
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirate...
2020-12-09 22:28
Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the...
2020-12-11 00:03
On behalf of the Board, Kenanga IB wishes to inform that Bursa Securities had, vide its letter dated 19 January 2021, approved the Transfer under the “Health Care” sector.
The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link.
This announcement is dated 20 January 2021.
https://www.bursamalaysia.com/market_information/announcements/company...
2021-01-21 08:36
so there's another announcement, and then have to wait for 2 days then only transfer to main board?
2021-02-07 15:28
Only Sinovac vaccine approved by NPRA and Pharmaniaga allowed to distribute not Nova Un Well.
Posted by donkeycharles > Jan 29, 2021 1:56 PM | Report Abuse
any news on hepar p clinical trials?
2021-03-02 23:15
Bursa is not strict enough such that many conmen successful con many ikan bilis.
2021-03-02 23:31
Shareholders just go to tiih for instance to view signed contracts and photos of signing also cannot meh?
2021-03-02 23:35
Once third trial test on hepar passes after a few years, it will add much value to Nova.
2021-05-09 20:55
Anyone knows Nova's new plant latest news? Is it already commissioning or still in construction?
2021-09-10 00:56
The Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
2021-11-09 21:11
Yesterday 22/11 saw Nova's truck running on Kepong road. Haha good sign to continue hold it
2021-11-23 01:04
Post a Comment
Featured Posts
1
I3investor
2
MQ Trader Announcement!
Apps
Top Articles
1
Good Articles to Share
Thailand: Singaporean driver killed in Phuket road accident, her four passengers injured
2
Good Articles to Share
Taiwan says 13 Chinese air force planes crossed Taiwan Strait median line
3
Good Articles to Share
4
Good Articles to Share
India dismisses four employees in Kashmir for anti-national activities
5
Good Articles to Share
6
Good Articles to Share
Vietnam logs 1,815 new coronavirus cases and one death on Saturday (Aug 13)
7
Good Articles to Share
Indonesia maintains high target of foreign tourist arrivals amid rising Covid-19 cases
8
Good Articles to Share
Second Indonesian political alliance formed amid jockeying for 2024 elections
Hot Stocks Today
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
donkeycharles
easily RM2 stock, 2 more years maybe
2020-12-06 13:16